The block deal constituted 0.06% of the company's equity.Meanwhile, the BSE Sensex was up 74.65 points, or 0.84%, to 8,977.77.On BSE, 97,178 shares were traded in the counter. The stock had an average daily volume of 6,952 shares in the past one quarter.The stock hit a high of Rs 1190 and a low of Rs 1156.10 so far during the day. The stock hit a 52-week high of Rs 1212 on 9 July 2008 and a 52-week low of Rs 800 on 22 January 2008.
The mid-cap stock had outperformed the market over the past one month till 24 November 2008, gaining 17.44% as compared to the Sensex's decline of 2.32%. It had also outperformed the market in the past one quarter, gaining 0.75% as compared to the Sensex's decline of 38.18%.
The company's current equity is Rs 84.70 crore. Face value per share is Rs 10.
The current price of Rs 1171.15 discounts the company's Q3 September 2008 annualized EPS of Rs 62.32, by a PE multiple of 18.79.
GlaxoSmithKline Pharma's net profit fell 47% to Rs 131.97 crore on 9.9% to Rs 464.68 crore in Q3 September 2008 over Q3 September 2007.
The company is engaged in manufacturing and marketing pharmaceutical and healthcare products such as betamethasone, cefuroxime and ranitidine.
No comments:
Post a Comment